Peritonitis after percutaneous endoscopic gastrojejunostomy for levodopa–carbidopa intestinal gel treatment despite concomitant use of gastropexy

Takashi Tsuboi; Hirohisa Watanabe; Kouhei Funasaka; Mikiko Takebayashi; Kazushi Miyata; Masahisa Katsuno

doi:10.1111/ncn3.12183

Peritonitis after percutaneous endoscopic gastrojejunostomy for levodopa–carbidopa intestinal gel treatment despite concomitant use of gastropexy

Takashi Tsuboi, Hirohisa Watanabe, Kouhei Funasaka, Mikiko Takebayashi, Kazushi Miyata, Masahisa Katsuno

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

Abstract

A 58-year-old man with Parkinson's disease experienced peritonitis after percutaneous endoscopic gastrojejunostomy (PEG-J) for levodopa–carbidopa intestinal gel treatment despite concomitant use of gastropexy. Although gastropexy reduces complications including peritonitis, clinicians should consider structural characteristics of PEG-J devices and patients’ anatomical differences. We recommend that suture threads are removed 2–4 weeks after PEG-J and that the PEG-J tube length outside the body is routinely recorded to assess tube dislocation.

Original language	English
Pages (from-to)	64-66
Number of pages	3
Journal	Neurology and Clinical Neuroscience
Volume	6
Issue number	2
DOIs	https://doi.org/10.1111/ncn3.12183
Publication status	Published - 03-2018
Externally published	Yes

All Science Journal Classification (ASJC) codes

Neurology
Clinical Neurology

Access to Document

10.1111/ncn3.12183

Cite this

@article{c0240c9e4af64c45b44c94791a7a5fea,

title = "Peritonitis after percutaneous endoscopic gastrojejunostomy for levodopa–carbidopa intestinal gel treatment despite concomitant use of gastropexy",

abstract = "A 58-year-old man with Parkinson's disease experienced peritonitis after percutaneous endoscopic gastrojejunostomy (PEG-J) for levodopa–carbidopa intestinal gel treatment despite concomitant use of gastropexy. Although gastropexy reduces complications including peritonitis, clinicians should consider structural characteristics of PEG-J devices and patients{\textquoteright} anatomical differences. We recommend that suture threads are removed 2–4 weeks after PEG-J and that the PEG-J tube length outside the body is routinely recorded to assess tube dislocation.",

keywords = "Parkinson's disease, gastropexy, levodopa–carbidopa intestinal gel, percutaneous endoscopic gastrojejunostomy, peritonitis",

author = "Takashi Tsuboi and Hirohisa Watanabe and Kouhei Funasaka and Mikiko Takebayashi and Kazushi Miyata and Masahisa Katsuno",

note = "Publisher Copyright: {\textcopyright} 2018 Japanese Society of Neurology and John Wiley \& Sons Australia, Ltd",

year = "2018",

month = mar,

doi = "10.1111/ncn3.12183",

language = "English",

volume = "6",

pages = "64--66",

journal = "Neurology and Clinical Neuroscience",

issn = "2049-4173",

publisher = "John Wiley and Sons Inc.",

number = "2",

}

TY - JOUR

T1 - Peritonitis after percutaneous endoscopic gastrojejunostomy for levodopa–carbidopa intestinal gel treatment despite concomitant use of gastropexy

AU - Tsuboi, Takashi

AU - Watanabe, Hirohisa

AU - Funasaka, Kouhei

AU - Takebayashi, Mikiko

AU - Miyata, Kazushi

AU - Katsuno, Masahisa

PY - 2018/3

Y1 - 2018/3

N2 - A 58-year-old man with Parkinson's disease experienced peritonitis after percutaneous endoscopic gastrojejunostomy (PEG-J) for levodopa–carbidopa intestinal gel treatment despite concomitant use of gastropexy. Although gastropexy reduces complications including peritonitis, clinicians should consider structural characteristics of PEG-J devices and patients’ anatomical differences. We recommend that suture threads are removed 2–4 weeks after PEG-J and that the PEG-J tube length outside the body is routinely recorded to assess tube dislocation.

AB - A 58-year-old man with Parkinson's disease experienced peritonitis after percutaneous endoscopic gastrojejunostomy (PEG-J) for levodopa–carbidopa intestinal gel treatment despite concomitant use of gastropexy. Although gastropexy reduces complications including peritonitis, clinicians should consider structural characteristics of PEG-J devices and patients’ anatomical differences. We recommend that suture threads are removed 2–4 weeks after PEG-J and that the PEG-J tube length outside the body is routinely recorded to assess tube dislocation.

KW - Parkinson's disease

KW - gastropexy

KW - levodopa–carbidopa intestinal gel

KW - percutaneous endoscopic gastrojejunostomy

KW - peritonitis

UR - https://www.scopus.com/pages/publications/85066895685

UR - https://www.scopus.com/inward/citedby.url?scp=85066895685&partnerID=8YFLogxK

U2 - 10.1111/ncn3.12183

DO - 10.1111/ncn3.12183

M3 - Article

AN - SCOPUS:85066895685

SN - 2049-4173

VL - 6

SP - 64

EP - 66

JO - Neurology and Clinical Neuroscience

JF - Neurology and Clinical Neuroscience

IS - 2

ER -

Peritonitis after percutaneous endoscopic gastrojejunostomy for levodopa–carbidopa intestinal gel treatment despite concomitant use of gastropexy

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this